Covered recipient · General Payments record
KENNETH SCHOT HANNAN
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$1,848.45
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $390.93 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $95.11 | 4 |
| Gilead Sciences, Inc. | $71.95 | 3 |
| Shionogi Inc | $69.00 | 3 |
| ABBVIE INC. | $53.08 | 3 |
| PFIZER INC. | $46.94 | 3 |
| Novavax Inc | $23.43 | 1 |
| Merck Sharp & Dohme Corporation | $16.39 | 1 |
| Paratek Pharmaceuticals, Inc. | $15.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.09 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103875268 | CMS |
| ABBVIE INC. | $17.83 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103875270 | CMS |
| ABBVIE INC. | $17.16 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103875272 | CMS |
| Astellas Pharma US Inc | $26.22 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139268266 | CMS |
| Astellas Pharma US Inc | $20.99 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139339744 | CMS |
| Astellas Pharma US Inc | $23.76 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139368153 | CMS |
| Astellas Pharma US Inc | $24.14 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139430110 | CMS |
| Gilead Sciences, Inc. | $29.04 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133818373 | CMS |
| Gilead Sciences, Inc. | $20.38 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133818375 | CMS |
| Gilead Sciences, Inc. | $22.53 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133818377 | CMS |
| Merck Sharp & Dohme LLC | $16.39 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141606873 | CMS |
| Novavax Inc | $23.43 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123373865 | CMS |
| Paratek Pharmaceuticals, Inc. | $15.03 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113902777 | CMS |
| PFIZER INC. | $14.20 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131302375 | CMS |
| PFIZER INC. | $16.87 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131911120 | CMS |
| PFIZER INC. | $15.87 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130878382 | CMS |
| Shionogi Inc | $23.17 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154338290 | CMS |
| Shionogi Inc | $29.09 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154338318 | CMS |
| Shionogi Inc | $16.74 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154338358 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.